OpGen Inc - OPGN Net Assets per Single Share

OpGen, Inc. automated molecular analysis systems accelerate the diagnosis of bacterial resistance, confirming the company's technological potential. The estimated book value per share clearly demonstrates the dynamics of reserves, where the -9.09 mark indicates the current value level. However, a deep management crisis and loss of investor confidence coincide with a critical reduction in microbiology staff due to debt restructuring.

Professional managers utilize fundamental filters to identify the intrinsic value of a business by analyzing the difference between total assets and liabilities per share. For OpGen, Inc. (OPGN), which operates in the stable hospital diagnostics segment, assessing the book value per share allows for tracking capital preservation and the impact of share issuances amid steady demand for medical tests.